Current Clinical Trials and Research

Cord blood has been used for 20 years to treat more than 80 serious diseases.34 Successful treatments have paved the way for further research and today, FDA-regulated clinical trials are exploring the use of a child’s own stem cells for conditions that currently have no cure.

Several of these groundbreaking trials only use cord blood stem cells processed by Cord Blood Registry as a way of ensuring consistent quality. That means, saving with Cord Blood Registry gives families access to more uses and treatments.

Cord blood stem cells are currently being evaluated as potential treatment for:

  • Autism
  • Pediatric Stroke
  • Traumatic brain injury
  • Cerebral palsy
  • Juvenile diabetes

Learn more about CBR's role in furthering stem cell research through the CBR Center for Regenerative Medicine.

Clinical Trials

NEW! Autism – Exclusive to CBR Clients

Dr. Michael Chez, director of pediatric neurology at Sutter Medical Center, is leading a landmark FDA-regulated clinical trial to test the use of a child’s own umbilical cord blood as a therapy to improve language and behavior in children with autism who have no obvious cause for the condition such as a known genetic syndrome or brain injury. Learn more

NEW! Pediatric Stroke – Exclusive to CBR Clients

A new clinical trial will investigate using a child’s own cord blood stem cells as treatment after a pediatric stroke. Below are details on how Cord Blood Registry is helping uncover new potential uses for cord blood stem cells. Learn more

Traumatic Brain Injury – Exclusive to CBR Clients

Dr. Charles Cox, professor of pediatric surgery at The University of Texas Health Science Center in Houston (UTHealth), is leading an FDA-regulated trial studying the safety of a child's own cord blood stem cells in the treatment of traumatic brain injury (TBI).
Learn more

Cerebral Palsy – Exclusive to CBR Clients

Dr. James Carroll at the Georgia Health Sciences University is conducting the first FDA-regulated clinical trial using cord blood stem cell infusions to treat children with cerebral palsy. This trial is open exclusively to children who have their cord blood banked with CBR. Learn more

Cerebral Palsy – Open to Families who Bank

Dr. Joanne Kurtzberg at Duke University is also conducting an FDA-regulated clinical trial evaluating a child's own cord blood stem cell infusions to help treat the effects of cerebral palsy.

Juvenile (type 1) Diabetes – No Longer Recruiting

The University of Florida is in the midst of a Phase II investigation of the use of a child’s own cord blood stem cells to prolong insulin production in those suffering from juvenile (type 1) diabetes. Beginning in 2006, a group of CBR clients and other children who had been diagnosed with the condition were identified and eventually enrolled in the Phase I trial. Today, the University of Florida researchers continue their work in a Phase II study. For more information about the Phase II trial, please click here.